ANALYSIS: Implementing the ACA post-election: Let the wild rumpus begin
This article was originally published in Scrip
While the Patient Protection and Affordable Care Act (ACA) and Medicare and Medicaid may have been spared a complete topsy-turvy set of events with President Barack Obama's 332-206 electoral vote win over former Massachusetts Governor Mitt Romney, there's no doubt knotty challenges – financial and otherwise – lie ahead, not only for all agencies within the Department of Health and Human Services (HHS), but for the 50 US states and industry as the law is further implemented.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.